- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT06777511
골유합 보철물 환자의 감염 예방을 위한 첨단 항균 광역학 치료
This will be a prospective observational trial enrolling 20 patients with osseointegrated prostheses. Participants will be recruited from the orthopaedic outpatient clinic at Walter Reed National Military Medical Center in Bethesda, MD.
All eligible consenting patients will undergo daily stoma management per standard of care.
Patients will integrate antimicrobial photodynamic therapy into their stoma management program. The first treatment will take place in the orthopaedic clinic. All others will take place at home. Topical 5-ALA will be applied to the metal at the penetration site. After 2 hours, the light delivery device will be utilized and light will be administered for 15 minutes.
Data collection: After obtaining informed consent, study personnel will record injury-specific variables, surgery-specific variables, other variables related to their hospital course, demographic variables as well as comorbidities on the study case report forms (CRFs). They will obtain this information directly from the participant, from the participant's medical record, and the participant's treating orthopaedic surgeon or other health care providers. Baseline data collection points include participant characteristics and amputation details such as age, sex, comorbidities, highest education level achieved, social support, initial reason for amputation, type of amputation and all surgical dates. Study participants will be followed at 1 and 2 weeks after initiation of PDT treatment. To ensure research participant safety, serious adverse events (SAEs) will be documented and promptly submitted to the local IRB as per the required reporting processes.
Follow-up: Study participants will be followed at 1 week and 2 weeks.
연구 개요
연구 유형
등록 (추정된)
연락처 및 위치
연구 연락처
- 이름: Devin Mullin
- 전화번호: 603-650-6032
- 이메일: Devin.S.Mullin@hitchcock.org
연구 연락처 백업
- 이름: Ida Gitajn
- 전화번호: 603-650-6032
- 이메일: Ida.Leah.Gitajn@hitchcock.org
연구 장소
-
-
Maryland
-
Bethesda, Maryland, 미국, 20889
- Walter Reed National Military Medical Center
-
연락하다:
- Christopher H Renninger, MD
- 전화번호: (202)-929-0618
- 이메일: christopher.h.renninger.mil@health.mil
-
연락하다:
- Qingfeng Liu
- 전화번호: (240) 645-3068
- 이메일: Qingfeng.liu.ctr@usuhs.edu
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
All patients >18 years with osseointegrated prostheses are eligible. Patients will be excluded if they have an ongoing infection, are pregnant or if it is anticipate that they will have issues with compliance or follow-up.
설명
Inclusion Criteria:
- All patients with osseointegrated prostheses 18 years of age or older
Exclusion Criteria:
- Ongoing infection
- Pregnant
- Anticipated issues with compliance or follow-up
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: COHORT
- 시간 관점: PROSPECTIVE
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
Osseointegration patients
All patients >18 years with osseointegrated prostheses. |
All patients who are recruited and enrolled into this study use topical 5- ALA, in combination with the light delivery device as part of their standard stoma management. All patients who are recruited and enrolled into this study use topical 5- ALA, in combination with the light delivery device photodynamic therapy device as part of their standard stoma management. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Feasibility
기간: 2 weeks
|
Feasibility will be defined as 80% of patients successfully completing the administration protocol as well as 1 week/2-week follow-up. |
2 weeks
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Treatment Evaluation Inventory-Short Form (TEI-SF)
기간: 2 weeks
|
The TEI-sf is a 9-item questionnaire used to measure intervention acceptability from the participants point of view. Scores range from 9 to 45, and scores above 27 are considered acceptable. |
2 weeks
|
|
System Usability Scale (SUS)
기간: 2 weeks
|
The SUS is a reliable 10-item usability measure with scores that range from 0 to 100 (an above average score is 68 or higher. |
2 weeks
|
|
Bioburden quantification (16S rRNA sequencing)
기간: 2 weeks
|
Bioburden will be quantified using quantitative PCR-based assays as well as addition of a "spikein" of a defined quantity of bacterial cells derived from halophilic organism Salnibacter ruber. |
2 weeks
|
|
Bioburden quantification (Optical Coherence Tomography (OCT)
기간: 2 weeks
|
Biofilm will be imaged and quantified on the metal abutment |
2 weeks
|
|
OCT "virtual biopsy"
기간: 2 weeks
|
Presence of inflammation, hypergranulation, and any resulting changes (e.g., the degree of epidermal regression, dermal attachment to the implant, and epithelial layer thickness) can be quantified through morphologic analysis of the OCT B-scans. Scars are characterized by excessive collagen deposition, increased blood vessel density, and parallel blood vessel organization compared with normal skin. |
2 weeks
|
|
Scar thickness
기간: 2 weeks
|
Scar thickness measured using OCT |
2 weeks
|
|
Blood vessel density
기간: 2 weeks
|
Blood vessel density measuring using OCT |
2 weeks
|
|
Presence of hypergranulation
기간: 2 weeks
|
Hypergranulation measured using OCT |
2 weeks
|
|
Pain during light exposure
기간: 2 weeks
|
Patient reported pain during light exposure |
2 weeks
|
|
Discomfort, burning, itchiness, or redness
기간: 2 weeks
|
Patient reported discomfort, burning, itchiness or redness |
2 weeks
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .